Invasive Breast Carcinoma — Trials

Invasive Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 103
Recruiting: 41
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02856503	Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors	withdrawn	Phase 1 / Phase 2	0	Eli Avisar, MDOTHER	0	Apr 17, 2026	clinicaltrials
NCT06590558	Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer	withdrawn	Phase 1	0	National Cancer Institute (NCI)NIH	0	Jul 3, 2025	clinicaltrials